Furthermore, the inhibitory effect of ACADL on NSCLC cells was confirmed in a xenografted tumor model, where ACADL overexpressing cells formed tumors at a significantly slower rate compared to the Control group in vivo. Here, ACADL is linked to non-small cell lung carcinoma.